Non-Carbohydrate Glycomimetics as Inhibitors of Calcium(II)-Binding Lectins.
Because of the antimicrobial resistance crisis, lectins are considered novel drug targets.
Because of the antimicrobial resistance crisis, lectins are considered novel drug targets.